Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Double-blind, Randomized, Prospective, Placebo-controlled Trial to Assess the Immunogenicity, Efficacy and Safety of the Coronavirus Vaccine in Healthy Volunteers Aged 18 Years and Older

NCT05726084 is registered in ClinicalTrials.gov with St. Petersburg Research Institute of Vaccines and Sera as lead sponsor.

NCT NCT05726084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05726084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Double-blind, Randomized, Prospective, Placebo-controlled Trial to Assess the Immunogenicity, Efficacy and Safety of the Coronavirus Vaccine in Healthy Volunteers Aged 18 Years and Older
Lead sponsor
St. Petersburg Research Institute of Vaccines and Sera
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 24, 2022
Completion date
December 30, 2023
Enrollment
16,304 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infections, covid-19, covid-19 respiratory infection, respiratory tract infections